Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.86
-0.13 (-1.00%)
Jun 1, 2026, 2:44 PM EDT - Market open
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 19.88 | 12.85 | -8.49 | -12.01 | 14.99 | 23.08 |
Depreciation & Amortization | 11.75 | 11.22 | 16.07 | 15.93 | 13.19 | 19.61 |
Stock-Based Compensation | 14.42 | 13.77 | 11.25 | 9.25 | 6.39 | 9.06 |
Other Adjustments | 4.19 | 9.02 | -0.17 | -15.73 | -10.57 | -8.99 |
Change in Receivables | -13.14 | -3.36 | -6.78 | -18.54 | 2.36 | 5.92 |
Changes in Inventories | -0.47 | -1.29 | -0.5 | -14.43 | -15.02 | -6.15 |
Changes in Accounts Payable | 22.27 | 14.13 | -2.77 | 16.23 | 11.99 | -5.19 |
Changes in Income Taxes Payable | -4.93 | -4.6 | -15.58 | -0.66 | -1.24 | - |
Changes in Other Operating Activities | 1.27 | 2.97 | 5.18 | 2.67 | 0.36 | 0.52 |
Operating Cash Flow | 56.43 | 54.71 | -1.8 | -17.3 | 22.46 | 37.84 |
Operating Cash Flow Growth | 827.48% | - | - | - | -40.65% | -54.75% |
Capital Expenditures | -0.71 | -0.75 | -0.79 | -1.44 | -1.38 | -10.74 |
Purchases of Intangible Assets | - | -0.01 | -0.01 | -0.03 | -0.6 | -5.98 |
Proceeds from Sale of Intangible Assets | - | - | - | 21.28 | - | - |
Purchases of Investments | -102.98 | -0.74 | -284.31 | -382.01 | - | -4.59 |
Proceeds from Sale of Investments | 35.48 | 85.23 | 316.73 | 232.81 | 7.3 | - |
Payments for Business Acquisitions | - | -57.48 | - | - | - | - |
Investing Cash Flow | -68.2 | 26.25 | 31.62 | -129.39 | 5.32 | -21.31 |
Long-Term Debt Issued | - | - | 104.54 | - | - | - |
Long-Term Debt Repaid | - | - | -134.92 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | -30.39 | - | - | - |
Issuance of Common Stock | 18.2 | 19.81 | 5.58 | 8.13 | 2.28 | 4.72 |
Net Common Stock Issued (Repurchased) | 18.2 | 19.81 | 5.58 | 8.13 | 2.28 | 4.72 |
Other Financing Activities | -23.23 | -18.32 | -9.61 | -9.17 | -7.26 | -32.67 |
Financing Cash Flow | -1.01 | 1.5 | -34.41 | -1.04 | -4.98 | -27.95 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 5.07 | 7.91 | -2.21 | 2.13 | -7.38 | -1.83 |
Net Cash Flow | -12.78 | 82.45 | -4.59 | -147.73 | 22.8 | -11.41 |
Free Cash Flow | 55.72 | 53.96 | -2.59 | -18.74 | 21.08 | 27.1 |
Free Cash Flow Growth | 3.27% | - | - | - | -22.21% | -65.68% |
FCF Margin | 15.08% | 14.35% | -0.87% | -7.64% | 10.25% | 13.63% |
Free Cash Flow Per Share | 0.73 | 0.72 | -0.03 | -0.26 | 0.30 | 0.39 |
Levered Free Cash Flow | 41.37 | 24.53 | -40.62 | 7.75 | 21.59 | 14.04 |
Unlevered Free Cash Flow | 64.32 | 68.26 | -3.61 | 12.25 | 27.74 | 15.77 |